Be Ready to Help Patients Switch Insulin

January 2024

You’ll get questions about how to switch patients off insulin detemir (Levemir)...since it will be discontinued in the US in 2024.

Anticipate supply disruptions of Levemir FlexPen soon...with market removal in April. Vials will be discontinued at year end.

Explain that it’s a business decision by the manufacturer...and reassure patients that the current supply is still safe to use.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote